Your browser doesn't support javascript.
loading
Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial.
Gershlick, Anthony H; Kandzari, David E; Banning, Amerjeet; Taggart, David P; Morice, Marie-Claude; Lembo, Nicholas J; Brown, W Morris; Banning, Adrian P; Merkely, Béla; Horkay, Ferenc; van Boven, Ad J; Boonstra, Piet W; Dressler, Ovidiu; Sabik, Joseph F; Serruys, Patrick W; Kappetein, Arie Pieter; Stone, Gregg W.
Affiliation
  • Gershlick AH; University Hospitals of Leicester, University of Leicester, Leicester Biomedical Research Centre, Leicester, United Kingdom. Electronic address: agershlick@aol.com.
  • Kandzari DE; Piedmont Heart Institute, Atlanta, Georgia.
  • Banning A; University Hospitals of Leicester, University of Leicester, Leicester Biomedical Research Centre, Leicester, United Kingdom.
  • Taggart DP; Department of Cardiac Surgery, John Radcliffe Hospital, Oxford, United Kingdom.
  • Morice MC; Ramsay Générale deSanté, Hopital Privé Jacques Cartier, Massy, France.
  • Lembo NJ; Piedmont Heart Institute, Atlanta, Georgia; Center for Interventional Vascular Therapy, Division of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.
  • Brown WM; Piedmont Heart Institute, Atlanta, Georgia.
  • Banning AP; Department of Cardiac Surgery, John Radcliffe Hospital, Oxford, United Kingdom.
  • Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Horkay F; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • van Boven AJ; Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands.
  • Boonstra PW; Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands.
  • Dressler O; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.
  • Sabik JF; Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
  • Serruys PW; International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Kappetein AP; Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Stone GW; Center for Interventional Vascular Therapy, Division of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.
JACC Cardiovasc Interv ; 11(13): 1224-1233, 2018 07 09.
Article in En | MEDLINE | ID: mdl-29976358
ABSTRACT

OBJECTIVES:

The authors sought to determine the extent to which the site of the left main coronary artery (LM) lesion (distal bifurcation versus ostial/shaft) influences the outcomes of revascularization with percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG).

BACKGROUND:

Among 1,905 patients with LM disease and site-assessed SYNTAX scores of <32 randomized in the EXCEL (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial, revascularization with PCI and CABG resulted in similar rates of the composite primary endpoint of death, myocardial infarction (MI), or stroke at 3 years.

METHODS:

Outcomes from the randomized EXCEL trial were analyzed according to the presence of angiographic core laboratory-determined diameter stenosis ≥50% involving the distal LM bifurcation (n = 1,559; 84.2%) versus disease isolated to the LM ostium or shaft (n = 293; 15.8%).

RESULTS:

At 3 years, there were no significant differences between PCI and CABG for the primary composite endpoint of death, MI, or stroke for treatment of both distal LM bifurcation disease (15.6% vs. 14.9%, odds ratio [OR] 1.08, 95% confidence interval [CI] 0.81 to 1.42; p = 0.61) and isolated LM ostial/shaft disease (12.4% vs. 13.5%, OR 0.90, 95% CI 0.45 to 1.81; p = 0.77) (pinteraction = 0.65). However, at 3 years, ischemia-driven revascularization occurred more frequently after PCI than CABG in patients with LM distal bifurcation disease (13.0% vs. 7.2%, OR 2.00, 95% CI 1.41 to 2.85; p = 0.0001), but were not significantly different in patients with disease only at the LM ostium or shaft (9.7% vs. 8.4%, OR 1.18, 95% CI 0.52 to 2.69; p = 0.68) (pinteraction = 0.25).

CONCLUSIONS:

In the EXCEL trial, PCI and CABG resulted in comparable rates of death, MI, or stroke at 3 years for treatment of LM disease, including those with distal LM bifurcation disease. Repeat revascularization rates during follow-up after PCI compared with CABG were greater for lesions in the distal LM bifurcation but were similar for disease isolated to the LM ostium or shaft.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Coronary Artery Bypass / Coronary Stenosis / Percutaneous Coronary Intervention Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JACC Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Coronary Artery Bypass / Coronary Stenosis / Percutaneous Coronary Intervention Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JACC Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2018 Type: Article